Interaction Between Age and Comorbidity as Predictors of Mortality After Radical Prostatectomy

Journal of Urology

Volumn 179, Issue 5, 2008, Pages 1823-1829

  Froehner, Michael ^a   Koch, Rainer ^a   Litz, Rainer J ^a   Hakenberg, Oliver W ^b   Oehlschlaeger, Sven ^a   Wirth, Manfred P ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

age groups; comorbidity; mortality; prostate; prostatic neoplasms

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; HEART FAILURE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORTALITY; ONSET AGE; PRIORITY JOURNAL; PROSTATECTOMY;

AGE FACTORS; AGED; COMORBIDITY; HUMANS; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 41749112199     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.01.023     Document Type: Article

References (18)

1. Bill-Axelson A., Holmberg L., Ruutu M., Häggman M., Andersson S.O., Bratell S., et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352 (2005) 1977
2. Klotz L. Active surveillance for prostate cancer: for whom?. J Clin Oncol 23 (2005) 8165
3. Singh R., and O'Brien T.S. Comorbidity assessment in localized prostate cancer: a review of currently available techniques. Eur Urol 46 (2004) 28
4. Hall W.H., Jani A.B., Ryu J.K., Vijayakumar S., and Narayani S. The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer. Prostate Cancer Prostatic Dis 8 (2005) 22
5. Froehner M., Koch R., Litz R.J., Hakenberg O.W., Oehlschlaeger S., and Wirth M.P. Comorbidity is a poor predictor of survival in patients undergoing radical prostatectomy after 70 years of age. Urology 68 (2006) 583
6. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373
7. ASA Physical Status Classification System. American Society of Anesthesiologists. Available at http://www.asahq.org/clinical/physicalstatus.htm. Accessed November 3, 2007.
8. Cardiovascular Disease Classification Chart. Cochran Foundation. Available at http://www.cochranfoundation.com/docs/nyha-class.htm. Accessed November 3, 2007.
9. Fowler Jr. J.E., Terrell F.L., and Renfroe D.L. Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy. J Urol 156 (1996) 1714
10. Heidenreich A, Aus G, Abbou CC, Bolla M, Joniau S, Matweev V et al: Guidelines on Prostate Cancer. European Association of Urology. Available at http://www.uroweb.org/fileadmin/user_upload/Guidelines/07_Prostate_Cancer_2007.pdf. Accessed November 3, 2007.
11. Thompson I, Thrasher JB, Aus G, Burnett AL, Canby-Hagino ED, Cookson MS et al: Prostate Cancer. Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update. American Urological Association Education and Research. Available at http://www.auanet.org/guidelines/main_reports/proscan07/content.pdf. Accessed November 3, 2007.
12. Albertsen P.C., Fryback D.G., Storer B.E., Kolon T.F., and Fine J. The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol 156 (1996) 127
13. Barry M.J., Albertsen P.C., Bagshaw M.A., Blute M.L., Cox R., Middleton R.G., et al. Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostatectomy, external beam radiotherapy, or expectant management: a retrospective analysis. Cancer 91 (2001) 2302
14. García-Miguel F.J., Serrano-Aguilar P.G., and López-Bastida J. Preoperative assessment. Lancet 362 (2003) 1749
15. Farnham S.B., Cookson M.S., Alberts G., Smith Jr. J.A., and Chang S.S. Benefit of radical cystectomy in the elderly patient with significant co-morbidities. Urol Oncol 22 (2004) 178
16. Reid B.C., Alberg A.J., Klassen A.C., Koch W.M., and Samet J.M. The American Society of Anesthesiologists' class as a comorbidity index in a cohort of head and neck cancer surgical patients. Head Neck 23 (2001) 985
17. Post P.N., Hansen B.E., Kil P.J.M., Janssen-Heijnen M.L.G., and Coebergh J.W.W. The independent prognostic value of comorbidity among men aged <75 years with localized prostate cancer: a population-based study. BJU Int 87 (2001) 821
18. de Vries S.H., Raaijmakers R., Kranse R., Blijenberg B.G., and Schröder F.H. Prostate cancer characteristics and prostate specific antigen changes in screening detected patients initially treated with a watchful waiting policy. J Urol 172 (2004) 2193